With the FDA release of the drug Uloric in 2009, the research and interest around gout and crystal arthropathies has exploded. Gout affects over 8 million Americans. The gout rate was 7% among Americans aged 60 to 79 in the early 1990s, compared with 9% by 2008. Among those aged 80 and older, the rate more than doubled, from 6% to 13% over the nearly 20-year time span. This topic has never been covered in Rheumatic Disease Clinics and it represents a large content hole. The articles will cover diagnosis, management, emerging therapies and imaging
By Richard D Brasington, Associate Professor of Medicine
Washington University, St Louis
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.